Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Microbiol. 1999 Aug;2(4):410-4.

Recent developments in the biology of respiratory syncytial virus: are vaccines and new treatments just round the corner?

Author information

  • 1Department of Respiratory Medicine, Imperial College School of Science, Technology and Medicine, National Heart and Lung Institute at St Mary's, Norfolk Place, London, W2 1PG, UK. t.hussel@ic.ac.uk

Abstract

Respiratory syncytial virus (RSV) is the major cause of infantile bronchiolitis, and is an important pathogen in the elderly and in the developing world. The production of full length cDNA clones now allows precise genetic engineering of RSV, while knowledge of the immunopathogenesis of augmented disease gives hope that effective vaccines will soon be developed.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk